JPMorgan Chase & Co. Reiterates “Neutral” Rating for Afya (NASDAQ:AFYA)

Afya (NASDAQ:AFYA)‘s stock had its “neutral” rating reiterated by research analysts at JPMorgan Chase & Co. in a report released on Wednesday,Benzinga reports. They currently have a $22.00 price target on the stock, down from their previous price target of $24.50. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 41.84% from the stock’s previous close.

A number of other equities research analysts have also recently commented on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th. Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, December 20th. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Afya currently has a consensus rating of “Hold” and an average target price of $18.13.

Afya Price Performance

Shares of AFYA stock opened at $15.51 on Wednesday. The firm’s 50 day moving average price is $14.70 and its two-hundred day moving average price is $15.16. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 0.98. Afya has a 52-week low of $13.47 and a 52-week high of $19.90. The stock has a market cap of $1.45 billion, a PE ratio of 11.16, a PEG ratio of 0.50 and a beta of 0.53.

Institutional Investors Weigh In On Afya

Large investors have recently modified their holdings of the business. Susquehanna International Group LLP bought a new position in shares of Afya during the 3rd quarter valued at about $419,000. Qube Research & Technologies Ltd acquired a new stake in Afya during the 3rd quarter worth approximately $610,000. Doma Perpetual Capital Management LLC raised its holdings in Afya by 50.6% during the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock worth $13,910,000 after buying an additional 299,419 shares during the period. Lazard Asset Management LLC lifted its stake in Afya by 167.6% in the third quarter. Lazard Asset Management LLC now owns 49,399 shares of the company’s stock valued at $771,000 after buying an additional 30,936 shares in the last quarter. Finally, Squarepoint Ops LLC acquired a new position in shares of Afya in the third quarter valued at approximately $191,000. 88.02% of the stock is currently owned by institutional investors.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.